Menora Mivtachim Holdings Ltd. Uro Gen Pharma Ltd. Transaction History

Menora Mivtachim Holdings Ltd.

$15.6 Billion
Q3 2024

A detailed history of Menora Mivtachim Holdings Ltd. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Menora Mivtachim Holdings Ltd. holds 2,303,031 shares of URGN stock, worth $26.4 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

2,303,031

Previous 2,303,031 -0.0%

Holding current value

$26.4 Million

Previous $38.6 Million 24.31%

% of portfolio

0.19%

Previous 0.27%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$8.84 - $22.64 $2 Million - $5.13 Million	-226,789 Reduced 8.96%	2,303,031 $32.3 Million
Q2 2023 Jul 31, 2023	SELL	$8.75 - $14.29 $3.41 Million - $5.56 Million	-389,183 Reduced 13.33%	2,529,820 $26.2 Million
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.41 $219,804 - $286,873	-30,486 Reduced 1.03%	2,919,003 $24.3 Million
Q2 2022 Aug 08, 2022	SELL	$5.12 - $8.74 $15,360 - $26,220	-3,000 Reduced 0.1%	2,949,489 $24.2 Million
Q4 2021 Feb 10, 2022	SELL	$9.03 - $19.13 $19,956 - $42,277	-2,210 Reduced 0.07%	2,952,489 $28.1 Million
Q1 2019 May 14, 2019	BUY	$35.47 - $54.55 $16.1 Million - $24.8 Million	454,829 Added 18.19%	2,954,699 $109 Million
Q2 2018 Aug 01, 2018	BUY	$48.35 - $65.33 $22 Million - $29.7 Million	454,241 Added 22.21%	2,499,870 $124 Million
Q1 2018 May 14, 2018	BUY	$38.64 - $57.54 $20.7 Million - $30.8 Million	535,622 Added 35.47%	2,045,629 $102 Million
Q4 2017 Feb 13, 2018	BUY	$27.28 - $43.26 $25.7 Million - $40.7 Million	940,418 Added 165.1%	1,510,007 $56.2 Million
Q3 2017 Oct 30, 2017	BUY	$17.15 - $32.72 $9.77 Million - $18.6 Million	569,589	569,589 $18 Million

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.

Account

Menora Mivtachim Holdings Ltd. Uro Gen Pharma Ltd. Transaction History